Highline Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-607,021
| Closed | -$52M | – | 27 |
|
|
2019
Q2 | $52M | Sell |
607,021
-459,228
| -43% | -$39.3M | 3.8% | 12 |
|
|
2019
Q1 | $94.7M | Buy |
1,066,249
+53,130
| +5% | +$4.72M | 5.95% | 3 |
|
|
2018
Q4 | $86.3M | Sell |
1,013,119
-273,831
| -21% | -$23.3M | 5.78% | 7 |
|
|
2018
Q3 | $125M | Sell |
1,286,950
-32,500
| -2% | -$3.15M | 5.77% | 6 |
|
|
2018
Q2 | $124M | Buy |
1,319,450
+45,550
| +4% | +$4.29M | 4.16% | 6 |
|
|
2018
Q1 | $103M | Buy |
+1,273,900
| New | +$103M | 3.52% | 12 |
|